Home > PsOlve: Innovation Challenge to improve holistic management and long-term wellbeing of people living with psoriasis > HQ-NOP-2400170_PsOlve_Legal Basis_Candidacy Template_FORM
Published on 19/12/2024
HQ-NOP-2400170_PsOlve_Legal Basis_Candidacy Template_FORM
Related News
Almirall and CRG collaborate to identify molecular pathways and biomarkers specific to atopic dermatitis.
Almirall, Barcelona Supercomputing Center (BSC) and Nostrum Biodiscovery collaborate to design new protein-protein modulators through Artificial Intelligence.
Related News
Published on 09/02/2024
Looking for new therapeutic approaches for AD
Almirall and CRG collaborate to identify molecular pathways and biomarkers specific to atopic dermatitis.
Published on 08/02/2024
Seeking new therapies through AI
Almirall, Barcelona Supercomputing Center (BSC) and Nostrum Biodiscovery collaborate to design new protein-protein modulators through Artificial Intelligence.
Published on 24/10/2023
AlmirallShare opens new call for proposals
We are looking for collaboration opportunites focused on pathological mechanisms common across different organs and tissues that can be translatable to skin diseases
HQ-NOP-2400170_PsOlve_Legal Basis_Candidacy Template_FORM
